Insider Transactions in Q1 2021 at Amgen Inc (AMGN)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
21,190
-3.47%
|
$5,170,360
$244.42 P/Share
|
|
Mar 19
2021
|
Murdo Gordon EVP, Global Commercial Ops |
SELL
Payment of exercise price or tax liability
|
Direct |
8,989
-17.82%
|
$2,193,316
$244.42 P/Share
|
|
Mar 19
2021
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,360
-8.92%
|
$1,063,840
$244.42 P/Share
|
|
Mar 19
2021
|
Nancy A. Grygiel SVP & CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
435
-3.48%
|
$106,140
$244.42 P/Share
|
|
Mar 19
2021
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
2,803
-7.39%
|
$683,932
$244.42 P/Share
|
|
Mar 19
2021
|
Linda H. Louie VP, Finance & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
115
-1.41%
|
$28,060
$244.42 P/Share
|
|
Mar 19
2021
|
David Piacquad SVP, Business Development |
SELL
Payment of exercise price or tax liability
|
Direct |
991
-2.18%
|
$241,804
$244.42 P/Share
|
|
Mar 19
2021
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,401
-3.19%
|
$341,844
$244.42 P/Share
|
|
Mar 19
2021
|
Esteban Santos EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
4,360
-8.16%
|
$1,063,840
$244.42 P/Share
|
|
Mar 10
2021
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
1,000
-5.95%
|
$231,000
$231.53 P/Share
|
|
Mar 10
2021
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.62%
|
$71,000
$71.64 P/Share
|
|
Mar 02
2021
|
Robert A Bradway Chairman, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
38,953
+6.0%
|
-
|
|
Mar 02
2021
|
Murdo Gordon EVP, Global Commercial Ops |
BUY
Grant, award, or other acquisition
|
Direct |
17,989
+26.4%
|
-
|
|
Mar 02
2021
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
8,725
+15.2%
|
-
|
|
Mar 02
2021
|
Nancy A. Grygiel SVP & CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,245
+9.12%
|
-
|
|
Mar 02
2021
|
Lori A Johnston EVP, HR |
BUY
Grant, award, or other acquisition
|
Direct |
5,608
+12.95%
|
-
|
|
Mar 02
2021
|
Linda H. Louie VP, Finance & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
467
+5.44%
|
-
|
|
Mar 02
2021
|
David Piacquad SVP, Business Development |
BUY
Grant, award, or other acquisition
|
Direct |
2,648
+5.5%
|
-
|
|
Mar 02
2021
|
David M Reese EVP & Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+6.03%
|
-
|
|
Mar 02
2021
|
Esteban Santos EVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
8,725
+14.08%
|
-
|
|
Feb 18
2021
|
Robert A Bradway Chairman, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
47,527
-7.69%
|
$11,168,845
$235.61 P/Share
|
|
Feb 18
2021
|
Robert A Bradway Chairman, CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
73,500
+10.62%
|
$3,969,000
$54.69 P/Share
|
|
Feb 16
2021
|
David M Reese EVP & Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,147
-2.73%
|
$271,839
$237.21 P/Share
|
|
Feb 16
2021
|
David M Reese EVP & Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,300
+5.19%
|
$124,200
$54.69 P/Share
|
|
Feb 10
2021
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
1,000
-5.95%
|
$238,000
$238.4 P/Share
|
|
Feb 10
2021
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.62%
|
$71,000
$71.64 P/Share
|
|
Feb 08
2021
|
R Sanders Williams Director |
SELL
Open market or private sale
|
Direct |
250
-5.09%
|
$59,250
$237.99 P/Share
|
|
Feb 07
2021
|
Lori A Johnston EVP, HR |
SELL
Payment of exercise price or tax liability
|
Direct |
474
-1.46%
|
$111,864
$236.32 P/Share
|
|
Feb 05
2021
|
Ellen Jamison Kullman Director |
BUY
Grant, award, or other acquisition
|
Direct |
16
+0.23%
|
-
|
|
Feb 04
2021
|
Jonathan P Graham EVP & Gen. Counsel & Secy. |
SELL
Open market or private sale
|
Direct |
11,110
-21.76%
|
$2,621,960
$236.51 P/Share
|
|
Jan 13
2021
|
Ronald D Sugar Director |
SELL
Open market or private sale
|
Direct |
1,000
-5.95%
|
$235,000
$235.99 P/Share
|
|
Jan 13
2021
|
Ronald D Sugar Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+5.62%
|
$71,000
$71.64 P/Share
|